Soc. Generale Call 75 HOT 21.06.2.../ DE000SV49CV2 /
03/06/2024 13:24:46 | Var.+0.200 | Denaro13:56:07 | Lettera13:56:07 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.720EUR | +7.94% | 2.690 Quantità in denaro: 2,000 |
2.780 Quantità in lettera: 2,000 |
HOCHTIEF AG | 75.00 EUR | 21/06/2024 | Call |
GlobeNewswire
14:07
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental W...
GlobeNewswire
14:05
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at...
GlobeNewswire
14:04
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
GlobeNewswire
14:01
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
GlobeNewswire
14:00
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Tre...
GlobeNewswire
14:00
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
GlobeNewswire
14:00
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome T...
GlobeNewswire
14:00
Core Molding Technologies to Present and Host 1x1 Meetings at the 14th Annual East Coast IDEAS Conf...
GlobeNewswire
14:00
CSW Industrials Names Darron Ash to Board of Directors, Supporting Commitment to Disciplined Capital...
GlobeNewswire
14:00
ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Sup...
GlobeNewswire
14:00
European Cup Inu: Transforming the Euro 2024 Experience with Innovative Crypto Betting
GlobeNewswire
14:00
Syntec Optics (Nasdaq: OPTX) to Participate in the “Charting the Course: Navigating the Intersection...
GlobeNewswire
14:00
Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fad...
GlobeNewswire
14:00
Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612)...